Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 for Type 2 Diabetes Prevention in Prediabetics
NCT01170468Phase 3Terminated
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Dec 2011
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Vitamin D3 with Placebo (2 arms). Primary endpoint: Incidence of Diabetes Mellitus at 2 years. Started Dec 2011; status: terminated.
02
Drugs
vitamin d
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01170468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01170468.